4//SEC Filing
Vazquez Martin 4
Accession 0001484612-23-000027
CIK 0001484612other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:18 PM ET
Size
9.2 KB
Accession
0001484612-23-000027
Insider Transaction Report
Form 4
Vazquez Martin
Chief Operating Officer
Transactions
- Sale
Common Stock
2023-03-01$22.33/sh−5,000$111,651→ 103,112 total - Exercise/Conversion
Performance Options (right to buy)
2023-03-01−5,000→ 43,507 totalExercise: $3.88Exp: 2027-12-19→ Common Stock (5,000 underlying) - Exercise/Conversion
Common Stock
2023-03-01$3.88/sh+5,000$19,400→ 108,112 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2022.
- [F2]The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from: $21.00 - $21.99 - 362 shares; $22.00 - $22.99 - 4,637 shares; $23.00 - $23.99 - 1 share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote.
- [F3]Includes 608 shares of Common Stock acquired pursuant to the Outset Medical, Inc. 2020 Employee Stock Purchase Plan ("ESPP"), for the purchase period of September 1, 2022 to February 28, 2023. This transaction is exempt from Rule 16b-3(c).
- [F4]In March 2021, following the expiration of the lock-up period in connection with our initial public offering, the applicable performance and market-based vesting conditions were met and the shares underlying this stock option award became fully vested.
Documents
Issuer
Outset Medical, Inc.
CIK 0001484612
Entity typeother
Related Parties
1- filerCIK 0001823380
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:18 PM ET
- Size
- 9.2 KB